HERBEST BIOTECH

Bringing Proven Medical Solutions to Taiwan Clinics

© HERBEST BIOTECH CO., LTD. ALL RIGHTS RESERVED.

HERBEST BIOTECH

CORPORATE PROFILE & FOUNDATIONS

HERBEST BIOTECH

Establishment & Positioning

Founded: Established in 2020, deeply rooted in the healthcare

and wellness industry.

Core Positioning: Dedicated to becoming Taiwan's premier

distributor of premium medical devices and regenerative

medicine products.

We act as a vital strategic catalyst, bridging cutting-edge

international advancements with local clinics and professional

practices.

Three Core Strategic Values

“We don’t just distribute products

— we make them work in clinics.”

1. Product Curation: Discovering and securing proven

international medical innovations of true clinical value.

2. Local Adoption: Driving successful clinical onboarding,

hands-on masterclasses, and tailored local promotion.

3. Long-Term Trust: Building robust, win-win relationships

across our extensive medical networks.

Establishment & Values Positioning & Background

STRATEGIC GEOGRAPHIC FOOTPRINT

HERBEST BIOTECH

Deeply Rooted in High-Potential Markets

Sourcing

advanced

painless

pain-management

technology

(StimOn),

targeted

recovery

skin

patches (Tuning Element), and premium therapeutic

support solutions (Hisamitsu).

Primary Market

Providing smart AI-driven skin profiling systems

(Evelab Insight / EveMuse), high-precision anti-aging

lifting threads (Vsorb), needle-free meso delivery

systems, and premium medical-grade exosomes.

Aesthetic Medicine Segment

Orthopedics & Rehabilitation Segment

3-STEP EXECUTION MODEL

HERBEST BIOTECH

Our Vision: To be Taiwan's most trusted partner for medical product introduction, technological

localization, and efficient clinic channel distribution.

Step 1: Introduce

Source and bring in international medical

brands with true, verifiable clinical evidence and

high patient safety profiles.

Step 2: Commercialize

Empower local clinics to successfully adopt

technologies through training, certification, and

tailored marketing support.

Step 3: Network

Build long-term, stable, and highly collaborative

medical networks that foster academic growth

and practice prosperity.

Vision & Strategic Roadmap Our Mission

EXECUTIVE MANAGEMENT

HERBEST BIOTECH

Daniel Chen

GENERAL MANAGER

20+ Years of Leadership: Extensive expertise driving aesthetics, biological, and medical

device industries in local markets.

Global Brand Experience: Successfully managed and scaled multiple top-tier international

medical equipment brands (including Fotona, Cooltouch, Candela, Syneron, Lumenis, VASER,

LPG, INDIBA and miraDry).

Operational Strategist: Deep expertise in establishing product market positioning and building

robust clinical sales systems from the ground up.

Proven Business Builder: Strong track record in building and scaling high-growth medical

product businesses in Taiwan.

Core Leadership Profile Executive Team

OUR BUSINESS STRUCTURE & HUMAN CAPITAL

HERBEST BIOTECH

~10

SPECIALISTS

Highly Efficient Strike Force

Sales Team (x10)

The operational core, maintaining high-

frequency, direct client relationships

across North, Central, and South Taiwan.

Marketing (x2)

Directs product positioning, branding

campaigns, clinical webinars, and annual

medical congress exhibitions.

Administration (x1)

Streamlines supply chain management,

logistical compliance, quality assurance,

and clinic-direct deliveries.

Clinical Support

On-site clinical education, training

sessions, and hands-on promotion at the

clinic level.

Operational Force Multiplier The Strike Team

IMPLEMENTATION FRAMEWORK: ONBOARDING TO MASTERY

HERBEST BIOTECH

Implementation Emphasis

A comprehensive onboarding process

encompasses team training, protocol

standardization, and live procedural

demonstrations at each partner clinic.

Clinical Education

Through specialized in-house workshops

and academic masterclasses, physicians

receive continuous advanced clinical

education.

Treatment Tailoring

In partnership with key opinion leaders

(KOLs), be spoke treatment protocols are

developed, refined, and optimized for clinical

excellence.

1. Deployment

2. Training

3. Refinement

Clinical Integration Pipeline Systematic Deployment Framework

COMPREHENSIVE VALUE CHAIN SYNERGY

HERBEST BIOTECH

Integrating Upstream with Downstream

Herbest Biotech seamlessly bridges the gap between scientific

innovation and downstream clinical application through targeted

ecosystem integration:

Upstream Innovation (BioCraft Lab Partner)

Collaborating with leading research labs to ensure raw biological activity

and therapeutic molecules meet clinical excellence.

The Activation Hub

Converting raw research into highly useful, optimized, stable clinical

solutions (such as active regenerative compounds).

Seamless Downstream Application

Delivering optimized products directly to our extensive, highly responsive

nationwide clinic network.

Upstream Innovation & Integration

STRATEGIC CHANNEL DISTRIBUTION DATA

HERBEST BIOTECH

Cooperating Clinic Network Market Reach

DIVERSIFIED PRODUCT SOURCING STRATEGY

HERBEST BIOTECH

Risk Mitigation & Product Portfolio Strategic Focus

EXECUTION IS OUR CORE ADVANTAGE

HERBEST BIOTECH

1. Depth

Maintaining highly trusted,

direct-to-owner relationships

with 400+ active partner clinics

in Taiwan.

2. Force

A specialized sales strike team

delivering premium B2B

consultation, onboarding, and

business modeling.

3. Speed

Highly streamlined workflow

enabling rapid product

compliance, import logistics,

and clinical rollout.

4. Influence

Active participation in top

aesthetic and rehabilitation

congresses, driving deep KOL

endorsement networks.

Our Four Pillars of Success Key Strengths

BUILDING MEDICAL KNOWLEDGE NETWORKS

HERBEST BIOTECH

Major Annual Exhibitions

We maintain a dominant presence at top-tier

congresses in Taiwan, including **AMWC Taipei**,

**ISDS Dermatology**, and **The Rehabilitation

Annual Meeting**, showcasing cutting-edge AI

diagnostic tools and biological solutions.

Self-Hosted Workshops

We host exclusive, high-frequency "Hands-on

Clinical Workshops". Key opinion leaders and

partner physicians share clinical protocols,

technical injection methods, and thread-lifting

demonstrations directly.

Continuous Education

Our dedicated clinical support team continuously

follows up with clinics to provide further training,

optimization of treatment recipes, advanced safety

guidance, and direct commercial support.

Active Clinical Engagement Academic Reach

OUR HISTORICAL JOURNEY & FUTURE PREPAREDNESS

HERBEST BIOTECH

Foundation & Establishment

Formal launch of Herbest

Biotech. Secured initial

premium aesthetic

product licenses and laid

the operational network

foundation.

Building the Aesthetics Channel

Significantly expanded our

aesthetic medicine client

network. Successfully

integrated EveMuse skin

profiling and PLT

regenerative factors across

Taiwan clinics.

Rehab, Orthopedics, & AI Expansion

Diversified strategically

into pain management and

orthopedics with the

rollout of StimOn.

Hardened core value

propositions by linking AI

diagnostics with biological

treatments.

2020

2021 - 2023

2024 - 2025

Our Growth Trajectory Milestones

FOCUSED GROWTH BASED ON STRONG LOCAL FOUNDATIONS

HERBEST BIOTECH

Deepen Existing Network (Vertical)

Next-Gen EBD & Lifting Market

Maximize Clinic Wallet Share: Expand high-margin

product adoption (PLT / exosomes) within our existing

400+ active partner clinics.

Utilizing proprietary platelet freeze-dried crystals to

expand biological injection portfolios, clinical trials, and

deep R&D integration with .

AI Diagnostic Ecosystem: Evelab: Taiwan’s No. 1

Diagnostics

Positioning Evelab as the undisputed skin diagnostics

authority. Actively deploying AI facial analyzers to establish

objective, data-backed clinical consultation standard.

Expanding into medical-grade Energy-Based Devices (EBD).

Leveraging dynamic MUSE facial 3D mapping as the gold

standard to scientifically validate before/after lifting

efficacy.

Future Expansion Strategy 2026 and Beyond

HERBEST BIOTECH

TORR RF – Taiwan Market Positioning & Strategy

HERBEST BIOTECH

Herbest Sales Leadership Team In Taiwan

North | Emma

(13 Yrs Experience)

Central | Irene

(16 Yrs Experience)

South | Peggy

(15 Yrs Experience)

Proven RF & EBD Track Record:

Collectively managed and sold top global systems, including

LPG, Endymed, Cynosure SXV, INDIBA, Ellman Pelléve,

and Pollogen TriPollar.

Zero Learning Curve for TORR RF:

The clinical mechanics and operational logic of these legacy

brands directly align with TORR RF, ensuring immediate

technical proficiency and rapid nationwide clinical onboarding.

HERBEST BIOTECH

TORR RF: Disruptive Innovation

Unbeatable Technology & Maximum ROI

TORR RF's unique design addresses key pain points in both clinical profitability and patient comfort.

Zero Consumables Advantage: Eliminating expensive cartridge costs

ensures unprecedented profit margins and extremely rapid ROI for Taiwan

clinics.

Patented Auto-Circular Head (68 rpm): Guarantees uniform energy delivery, prevents

thermal hotspots, and eliminates risk of superficial burns.

Vibro-Comfort Mode (10,000 bpm): Distributes heat energy painlessly via the Gate

Control Theory, removing the need for anesthesia.

HERBEST BIOTECH

Target Segments & Market Penetration: Aesthetic Focus

Herbest Core Base

Our Immediate Launch Pad (Phase 1 Baseline)

•Herbest Current Base: 280+ Active Premium Aesthetic

Clinics (70% of our established network).

•Launch Strategy: These highly trusted, direct-to-owner

accounts serve as our immediate seed sites for high-

frequency TORR RF demo rollouts and rapid initial

onboarding.

Scaling Across Taiwan’s ~2,500+ Aesthetic Accounts

1. Independent Dermatology & Aesthetic Clinics (~1,500+ Sites)

2. Anti-Aging & Luxury Wellness Centers (~700+ Sites)

3. Premium Plastic Surgery Chains & Medical Groups (~300+ Sites)

HERBEST BIOTECH

Market Competition & Strategic Opportunities 1

1. Direct RF Competitors:

The Landscape:

INDIBA (500kHz),

Winback (300kHz–1MHz),

EndyMed

Venus Freeze.

Pollogen Tripollar

Competitor Vulnerabilities & Market Gaps:

High Operator Fatigue: Legacy capacitive/resistive RF systems like INDIBA and Winback are heavily reliant on manual therapist labor

and specific techniques, leading to inconsistent clinical results and high staff turnover.

Consumable Burden: Systems like EndyMed carry ongoing consumable costs, severely cutting into clinic net profit margins amid rising

operational overhead.

Aging Technology: Venus Freeze and Pollogen Tripollar represents an older generation of technology, creating a massive wave of

clinics actively looking for a premium, next-gen upgrade.

The TORR RF Disruption: Completely eclipses direct RF competitors via the patented 68 rpm auto-circular motion (eliminating

manual labor), Vibro-Comfort painless mode, and zero consumable cartridges for unbeatable clinical ROI.

HERBEST BIOTECH

Market Competition & Strategic Opportunities 2

2. Microwave Competitors: The Cross-Selling Moat & Upsell Opportunity

The Landscape: Onda Pro and PTING Ultra Microwave.

The Strategic Pivot (Turning Threats into Qualified Leads):

Pre-Qualified Premium Accounts: Clinics that have already purchased Onda Pro or PTING are verified, high-spending, premium

accounts with a deeply established clientele for high-end tightening and body contouring.

Perfect Portfolio Synergy: TORR RF does not conflict with microwave tissue-interaction; instead, it acts as the ideal RF

companion workstation.

The Zero-Consumable Leverage: Because TORR RF carries zero consumable overhead, these advanced clinics can

effortlessly bundle TORR RF with their existing microwave treatments. This allows them to create high-margin hybrid lifting

protocols and increase patient treatment frequency without adding to their cost base.

HERBEST BIOTECH

TORR RF Taiwan Launch Timeline

Phase 1: 2026 Q2-2027 Q2

Regulatory Prep

Aligning documentation specs with BRITZMEDI.

Allison coordinates the TFDA Class II filing pipeline.

Phase 2 2026 Q4~

Clinical Seed KOLs

Placing early evaluation units in key academic centers to establish

customized Taiwanese clinical protocols.

Phase 3: 2027 Q2

Launch

Hosting hands-on certification workshops with Korean

medical trainer to drive early TORR RF adoption.

Phase 4 2027 Q1-Q2

Exhibition

2027 March Spring TAAM Conference

2027 April Spring TSPLM Annual Meeting

2027 May AMWC Taipei

Partner with Herbest Biotech

Connecting breakthrough global biodevices with clinical market leaders in

Taiwan.

We help global products succeed through expert local execution.

WE LOOK FORWARD TO YOUR COLLABORATION

HERBEST BIOTECH